Pfizer revenue worse than expected as generic competition weighs

Pfizer Inc on Tuesday reported worse-than-expected third quarter revenue and lowered the top end of its full-year sales forecast as generic competition and drug pricing pressure in the United States hurt its older drugs business.


Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

two × three =